Luoxin Pharmaceutical issued a profit warning, expecting a net profit attributable to the parent company of 22.7 million to 25.2 million yuan in the first three quarters, turning losses into profits

According to the Zhitong Finance APP, Luoxin Pharmaceutical (002793.SZ) disclosed its performance forecast for the first three quarters of 2025. The company expects a net profit attributable to shareholders of the listed company to be between 22.7 million yuan and 25.2 million yuan, turning a profit; the net profit after deducting non-recurring gains and losses is expected to be between 4.7 million yuan and 5.9 million yuan